Antidiabetic drugs/drug classes Flashcards
MOA: Increases insulin release
sulfonylureas
MOA: agonist at PPARy receptors
TZDs - pioglitazone, rosigltizone
MOA: decreases hepatic gluconeogenesis
metformin
MOA: increases insulin sensitivity
TZDs - pioglitazone, rosigltizone
MOA: increases activity life of endogenous GLP1 by inhibiting the metabolic enzyme
DPP4-i
MOA: increases glucose-dependent insulin repease, slows gastric emptying, improves satiety
GLP1 agonists
MOA: increases loss of glucose in urine
SGLT2 i
Recommended 1st line treatment for T2DM
metformin
Class of antidiabetic drugs that commonly causes hypoglycemia
sulfonylureas, insulin
lactic acidosis is a rare but serious side effect
metformin
antidiabetic that may cause edema or fluid retention
TZDs - pioglitazone, rosigltizone
Should be stopped for at least 48 hours following IV contrast
metformin
Classes of antidiabetic drugs that may help with weight loss
metformin
GLP1i
SGLT2i
Classes of antidiabetic drugs that may cause weight gain
sulfonylurea - glipizide, glimepride
TZDs - pioglitazone, rosigltizone
insulin